RARA and acute promyelocytic leukemia: In conclusion, our data show that down-modulation of the transcription factor FOXC1 is a consistent feature of APL, occurring as a consequence of binding of the oncogenic protein PML-RARA to the FOXC1 promoter, and to FOXC1 hypermethylation.